The new in vivo-jetRNA®+ transfection reagent an efficient, stable, and safe delivery system leading to 100% mR...
Japan-based EditForce has entered into a license agreement with Mitsubishi Tanabe Pharma Corporation (MTPC) to research,...
US-based startup VerImmune and Fosun Pharma in China have entered into an exclusive license and option agreement. ...
Daewoong Pharmaceutical has signed a joint research and development agreement with UCI Therapeutics (CEO Sooyoung Jung),...
ImmuneOncia Therapeutics, Inc., a clinical-stage, immuno-oncology startup in South Korea, has announced that a Memorandu...
What additional scientific data did you have to submit to the US FDA for obtaining interchangeable biosimilar approval f...
BeiGene, headquartered in China, has purchased a 42-acre site at the Princeton West Innovation Campus in Hopewell, N.J.,...
KeyPlants is a leading international industry partner for standardized as well as customized process-integrated modular ...
A team of clinicians and scientists from the National Cancer Centre Singapore (NCCS), Singapore General Hospital (SGH) a...
ProBioGen and ValenzaBio jointly initiate a cell line development project involving the application of ProBioG...
Bioreactor technology has evolved over time and is still expanding as its requirements in biopharmaceutical and biotechn...
BeiGene, Ltd., a commercial-stage biotechnology company focused on developing and commercializing innovative medicines w...
Biocon Ltd, an innovation-led global biopharmaceuticals company based in India, announced that the Board of its subsidia...
South Korea's Celltrion Inc. said it will spend 600 billion won (US$520 million) on its new plant in China over the next...
The biologics industry in Asia- Pacific is estimated to be the fastest-growing market in the world. For instance, Asia- ...
Asia’s premier biopharmaceuticals company, has announced that its subsidiary, Biocon Biologics, has acquired R&...
I-Mab Biopharma ("I-Mab"), a clinical stage biotech company exclusively focusing on discovery and development of innovat...
Researchers from Duke-NUS Medical School, Singapore have uncovered a potential mechanism behind cancer suppression in ba...
